CANCER LETTERS Journal

publication venue for

Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia. 588. 2024
Reversible promoter demethylation of PDGFD confers gemcitabine resistance through STAT3 activation and RRM1 upregulation. 567. 2023
Enzalutamide-induced and PTH1R-mediated TGFBR2 degradation in osteoblasts confers resistance in prostate cancer bone metastases. 525:170-178. 2022
Proton pump inhibitors suppress DNA damage repair and sensitize treatment resistance in breast cancer by targeting fatty acid synthase. 509:1-12. 2021
eIF3i regulation of protein synthesis, cell proliferation, cell cycle progression, and tumorigenesis. 500:11-20. 2021
Repurposing metformin, simvastatin and digoxin as a combination for targeted therapy for pancreatic ductal adenocarcinoma. 491:97-107. 2020
BIRC5 is a target for molecular imaging and detection of human pancreatic cancer. 457:10-19. 2019
A novel synthetic human insulin super promoter for targeting PDX-1-expressing pancreatic cancer. 418:75-83. 2018
Single-cell RNA sequencing reveals diverse intratumoral heterogeneities and gene signatures of two types of esophageal cancers. 438:133-143. 2018
Single-cell Transcriptome Analyses Reveal Molecular Signals to Intrinsic and Acquired Paclitaxel Resistance in Esophageal Squamous Cancer Cells. 420:156-167. 2018
The dopamine D-3 receptor antagonists PG01037, NGB2904, SB277011A, and U99194 reverse ABCG2 transporter-mediated drug resistance in cancer cell lines. 396:167-180. 2017
Pyrimido[1 '',2 '':1,5]pyrazolo[3,4-b]quinolines: Novel compounds that reverse ABCG2-mediated resistance in cancer cells. 376:118-126. 2016
Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models. 328:307-317. 2013
Raf kinase inhibitor protein suppresses nuclear factor-kappa B-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression. 299:137-149. 2010
Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2. 279:74-83. 2009
Steroid receptors in human lung cancer cytosols. 16:327-332. 1982
Drug delivery and targeting to chemoresistant pancreatic cancer 2024
Unveiling cancer dormancy: Intrinsic mechanisms and extrinsic forces 2024
eIF3a: A new anticancer drug target in the eIF family 2018
Role of chemokines in tumor growth 2007

category

ONCOLOGY Category

International Standard Serial Number (ISSN)

0304-3835

Electronic International Standard Serial Number (EISSN)

1872-7980

journal abbreviation

CANCER LETT